What is he best known for?
The fields of study he is best known for:
- Gene
- Internal medicine
- Cancer
Sung-Hoon Kim mainly investigates Biochemistry, Cell biology, Molecular biology, Aminoacyl tRNA synthetase and Transfer RNA.
His study focuses on the intersection of Cell biology and fields such as Ubiquitin with connections in the field of Downregulation and upregulation and Programmed cell death.
His work deals with themes such as Cell culture, Cytoplasm and Cytokine, which intersect with Molecular biology.
The various areas that he examines in his Aminoacyl tRNA synthetase study include Mutation, Computational biology and Protein biosynthesis.
His Transfer RNA research incorporates elements of Peptide sequence and Enzyme.
His Amino acid study combines topics from a wide range of disciplines, such as mTORC1 and Leucyl-tRNA synthetase.
His most cited work include:
- Leucyl-tRNA Synthetase Is an Intracellular Leucine Sensor for the mTORC1-Signaling Pathway (555 citations)
- PHD1 controls muscle mTORC1 in a hydroxylation-independent manner by stabilizing leucyl tRNA synthetase. (483 citations)
- The BioMart community portal: an innovative alternative to large, centralized data repositories (468 citations)
What are the main themes of his work throughout his whole career to date?
The scientist’s investigation covers issues in Photochemistry, Internal medicine, Surgery, Biochemistry and Cell biology.
His studies deal with areas such as Acceptor, Moiety, Fluorescence and Absorption spectroscopy as well as Photochemistry.
His Internal medicine research incorporates themes from Gastroenterology, Endocrinology and Oncology.
His Biochemistry study focuses mostly on Aminoacyl tRNA synthetase and Transfer RNA.
He most often published in these fields:
- Photochemistry (14.43%)
- Internal medicine (9.60%)
- Surgery (7.61%)
What were the highlights of his more recent work (between 2016-2021)?
- Internal medicine (9.60%)
- Cancer research (5.23%)
- Cell biology (5.69%)
In recent papers he was focusing on the following fields of study:
Internal medicine, Cancer research, Cell biology, Ovarian cancer and Oncology are his primary areas of study.
His research on Internal medicine frequently links to adjacent areas such as Gastroenterology.
His Cancer research study frequently links to other fields, such as In vivo.
As a part of the same scientific family, Sung-Hoon Kim mostly works in the field of Cell biology, focusing on Protein biosynthesis and, on occasion, Aminoacyl tRNA synthetase.
Sung-Hoon Kim works mostly in the field of Ovarian cancer, limiting it down to concerns involving Chemotherapy and, occasionally, Debulking.
His Debulking research integrates issues from Stage, Surgery and Hazard ratio.
Between 2016 and 2021, his most popular works were:
- PHD1 controls muscle mTORC1 in a hydroxylation-independent manner by stabilizing leucyl tRNA synthetase. (483 citations)
- Tumor Suppressor miRNA-204-5p Regulates Growth, Metastasis, and Immune Microenvironment Remodeling in Breast Cancer (48 citations)
- Aminoacyl-tRNA synthetases as therapeutic targets. (45 citations)
In his most recent research, the most cited papers focused on:
- Internal medicine
- Gene
- Cancer
His primary scientific interests are in Cell biology, Internal medicine, Ovarian cancer, Oncology and Debulking.
His biological study spans a wide range of topics, including Secretion and Protein biosynthesis.
His research integrates issues of Aminoacyl tRNA synthetase, Transfer RNA and Computational biology in his study of Protein biosynthesis.
The study incorporates disciplines such as Carboplatin, Cancer research and Chemotherapy in addition to Ovarian cancer.
His Debulking research includes themes of Stage, Surgical oncology, Surgery, Hazard ratio and Radical surgery.
His mTORC1 study falls within the topics of Biochemistry and PI3K/AKT/mTOR pathway.
This overview was generated by a machine learning system which analysed the scientist’s
body of work. If you have any feedback, you can
contact us
here.
